Literature DB >> 27824290

Design and Use of Chimeric Proteins Containing a Collagen-Binding Domain for Wound Healing and Bone Regeneration.

Cyril Addi1, Frederic Murschel1, Gregory De Crescenzo1.   

Abstract

Collagen-based biomaterials are widely used in the field of tissue engineering; they can be loaded with biomolecules such as growth factors (GFs) to modulate the biological response of the host and thus improve its potential for regeneration. Recombinant chimeric GFs fused to a collagen-binding domain (CBD) have been reported to improve their bioavailability and the host response, especially when combined with an appropriate collagen-based biomaterial. This review first provides an extensive description of the various CBDs that have been fused to proteins, with a focus on the need for accurate characterization of their interaction with collagen. The second part of the review highlights the benefits of various CBD/GF fusion proteins that have been designed for wound healing and bone regeneration.

Keywords:  biomedical engineering; bone; collagen; extracellular matrix; growth factors; wound healing

Mesh:

Substances:

Year:  2016        PMID: 27824290     DOI: 10.1089/ten.TEB.2016.0280

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  8 in total

1.  Targeted antibody and cytokine cancer immunotherapies through collagen affinity.

Authors:  Jun Ishihara; Ako Ishihara; Koichi Sasaki; Steve Seung-Young Lee; John-Michael Williford; Mariko Yasui; Hiroyuki Abe; Lambert Potin; Peyman Hosseinchi; Kazuto Fukunaga; Michal M Raczy; Laura T Gray; Aslan Mansurov; Kiyomitsu Katsumata; Masashi Fukayama; Stephen J Kron; Melody A Swartz; Jeffrey A Hubbell
Journal:  Sci Transl Med       Date:  2019-04-10       Impact factor: 17.956

2.  Novel 3D Hybrid Nanofiber Aerogels Coupled with BMP-2 Peptides for Cranial Bone Regeneration.

Authors:  Lin Weng; Sunil Kumar Boda; Hongjun Wang; Matthew J Teusink; Franklin D Shuler; Jingwei Xie
Journal:  Adv Healthc Mater       Date:  2018-03-02       Impact factor: 9.933

3.  Use of Collagen Binding Domains to Deliver Molecules to the Cornea.

Authors:  Jes K Klarlund; Jake D Callaghan; Nicholas A Stella; Regis P Kowalski; Nancy A McNamara; Robert M Q Shanks
Journal:  J Ocul Pharmacol Ther       Date:  2019-10-10       Impact factor: 2.671

4.  Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy.

Authors:  Koichi Sasaki; Jun Ishihara; Ako Ishihara; Risako Miura; Aslan Mansurov; Kazuto Fukunaga; Jeffrey A Hubbell
Journal:  Sci Adv       Date:  2019-08-14       Impact factor: 14.136

Review 5.  Developing Regenerative Treatments for Developmental Defects, Injuries, and Diseases Using Extracellular Matrix Collagen-Targeting Peptides.

Authors:  Leora Goldbloom-Helzner; Dake Hao; Aijun Wang
Journal:  Int J Mol Sci       Date:  2019-08-21       Impact factor: 5.923

Review 6.  Therapeutic vascularization in regenerative medicine.

Authors:  Roberto Gianni-Barrera; Nunzia Di Maggio; Ludovic Melly; Maximilian G Burger; Edin Mujagic; Lorenz Gürke; Dirk J Schaefer; Andrea Banfi
Journal:  Stem Cells Transl Med       Date:  2020-01-10       Impact factor: 6.940

7.  Engineering an enthesis-like graft for rotator cuff repair: An approach to fabricate highly biomimetic scaffold capable of zone-specifically releasing stem cell differentiation inducers.

Authors:  Can Chen; Qiang Shi; Muzhi Li; Yang Chen; Tao Zhang; Yan Xu; Yunjie Liao; Shulin Ding; Zhanwen Wang; Xing Li; Chunfeng Zhao; Lunquan Sun; Jianzhong Hu; Hongbin Lu
Journal:  Bioact Mater       Date:  2022-01-05

8.  A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer.

Authors:  Jiayang Liu; Zhefeng Meng; Tongyang Xu; Kudelaidi Kuerban; Songna Wang; Xuyao Zhang; Jiajun Fan; Dianwen Ju; Wenzhi Tian; Xuan Huang; Xiting Huang; Danjie Pan; Huaning Chen; Weili Zhao; Li Ye
Journal:  Front Immunol       Date:  2022-03-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.